Inaktiver Wert

Andere Sprachen Medivir AB (publ) OTC Markets

Aktien

A3EFZT

SE0020181014

MVRBF

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Resolutions at the Annual General Meeting in Medivir on 7 May 2024	07.05.
Medivir Aktiebolag Approves Board Appointments	07.05.
BioStock: Double thumbs up for Medivir from the FDA	03.05.
MEDIVIR AB - INTERIM REPORT JANUARY - MARCH 2024	30.04.
Medivir AB Reports Earnings Results for the First Quarter Ended March 31, 2024	30.04.
Medivir brings the Q1 webcast forward to 10 a.m. on April 30	29.04.
Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI	29.04.
Medivir AB Provides Update from Positive Type C Meeting with the FDA; Preparations for Enhanced Phase 2b in HCC with Fostrox + Lenvima	29.04.
BioStock: Medivir optimizes study design after meeting FDA	26.04.
Medivir Gets Two US FDA Designations for MIV-711	25.04.
Medivir : FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease	25.04.
FDA grants Medivir's MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease	25.04.
FDA Grants Medivir AB´S MIV-711 Rare Pediatric Disease Designation for the Treatment of Legg-Calvé-Perthes Disease	25.04.
Medivir provides update from supportive Type C meeting with the FDA; preparations for enhanced phase 2b in HCC with fostrox + Lenvima continue	23.04.
BioStock: Medivir's partner makes clinical progress in veterinary project	19.04.
Medivir : The Board of Directors statement under Chapter 19 Section 22 of the Swedish Companies Act	16.04.
Medivir's partner Vetbiolix announces positive results from Proof-of-Concept study with VBX-1000, previously known as MIV-701	15.04.
BioStock: Medivir continues to accelerate development with fostrox	12.04.
Medivir : The Nomination Committees proposal for the AGM	09.04.
Medivir to present at Investing in Oncology Forum on April 10	09.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Medivir AB (publ) OTC Markets

Aktien

A3EFZT

SE0020181014

MVRBF

Andere Sprachen

Filter